Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer

  • Christina Pappa
  • , Khadra Galaal
  • , Sarah Smyth
  • , Robert E. Bristow
  • , Ali S. Khashan
  • , Mo'iad Alazzam

Research output: Contribution to journalArticlepeer-review

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To evaluate the benefits and harms of secondary CRS and chemotherapy in comparison to chemotherapy alone for women with platinum-sensitive recurrent epithelial ovarian cancer.

Original languageEnglish
Article numberCD015297
JournalCochrane Database of Systematic Reviews
Volume2024
Issue number6
DOIs
Publication statusPublished - 27 Jun 2024

Fingerprint

Dive into the research topics of 'Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer'. Together they form a unique fingerprint.

Cite this